Literature DB >> 32318699

Extranodal Marginal Zone Lymphoma of the Central Nervous System Includes Parenchymal-Based Cases With Characteristic Features.

Laila Nomani1, Claudiu V Cotta1, Eric D Hsi1, Judith A Ferry2, James R Cook1.   

Abstract

OBJECTIVES: To define the clinicopathologic features of extranodal marginal zone lymphoma (EMZL) of the central nervous system (CNS), including cases arising in CNS parenchyma, which have been reported only rarely.
METHODS: Twelve cases of CNS EMZL were identified, including 5 based in CNS parenchyma and 7 nonparenchymal cases arising in dura or choroid plexus.
RESULTS: Histologically, parenchymal cases were perivascular infiltrates without a dominant lymphoid mass, whereas nonparenchymal cases were masses of small lymphocytes. Plasma cells were a larger component of the infiltrate in parenchymal cases (median, 30%; range, 20%-50%) than nonparenchymal cases (median, 0%; range, 0%-5%; P < .001), and plasma cells were clonal by immunohistochemistry in 4 of 5 parenchymal vs 1 of 7 nonparenchymal cases (P = .07). Fluorescence in situ hybridization for MALT1 rearrangement was positive in 1 of 3 parenchymal and none of 3 nonparenchymal cases. Chromosomal microarray was abnormal in 5 of 7 cases (71%), with chromosome 6/6q alterations identified in 3 cases. No patients with parenchymal disease but all 6 (100%) with nonparenchymal disease achieved complete remission.
CONCLUSIONS: This case series, the first to include multiple parenchymal cases, clarifies the spectrum of clinical, pathologic, and genetic findings in CNS EMZL and suggests that parenchymal-based lesions may show less favorable prognosis than dural-based disease. © American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Central nervous system lymphoma; Extranodal marginal zone lymphoma; MALT lymphoma

Mesh:

Year:  2020        PMID: 32318699     DOI: 10.1093/ajcp/aqaa032

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.

Authors:  Clément Desjardins; Delphine Larrieu-Ciron; Sylvain Choquet; Karima Mokhtari; Frédéric Charlotte; Lucia Nichelli; Bertrand Mathon; Guido Ahle; Magali Le Garff-Tavernier; Andrea Morales-Martinez; Caroline Dehais; Khê Hoang-Xuan; Caroline Houillier
Journal:  J Neurooncol       Date:  2022-06-20       Impact factor: 4.506

Review 2.  Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.

Authors:  Marietya I S Lauw; Calixto-Hope G Lucas; Robert S Ohgami; Kwun Wah Wen
Journal:  Diagnostics (Basel)       Date:  2020-12-11

3.  Intraparenchymal Mucosa-Associated Lymphoid Tissue Lymphoma: A Case Report.

Authors:  Pedram Laghaei Farimani; Vishwathsen Karthikeyan; Mostafa Fatehi; Adrian Levine; Graham W Slack; Ian R Mackenzie; Charles Haw
Journal:  Cureus       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.